Plasmacytoma - 153 Studies Found Recruiting : Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma : Plasmacytoma : 2015-07-28 : Drug: Lenalidomide Experimenta Recruiting : Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone : Solitary Osseous Plasmacytoma : 2015-08-04 : Drug: ixazomib oral Terminated : S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma : Multiple Myeloma Plasmacytoma : 2005-05-03 : Procedure: magnetic resonance imaging Terminated : CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma : Extramedullary Plasmacytoma : 2015-01-08 : Drug: CDD Chemotherapy Completed : Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma : Multiple Myeloma Plasmocytoma : 2009-10-01 : Biological: autologous idiotype-protein pulsed dendritic cells Vaccination with autologous idiotype-prot Completed : Phase I/II Study of hLL1 in Multiple Myeloma : Multiple Myeloma Myeloma, Plasma-Cell Multiple Myeloma Plasma Cell Myeloma Precancerous Conditio : 2009-05-09 : Genetic: cytogenetic analysis Genetic: mic Recruiting : Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia : Plasma Cell Leukemia Plasma Cell Myeloma Drug: Dexamethasone Given PO Not yet recruiting : MDM2 Inhibitor AMG-232, Carfilzomib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma : Hypercalcemia Plasmacytoma Re : 2017-01-25 : Drug: Carfilzomib Given IV Completed : Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation : Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Chronic Lymphocy : 2009-09-24 : Procedure: Single fraction radiation Next >>>
